096240 — Creverse Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩160bn
- KR₩248bn
- KR₩233bn
- 83
- 81
- 80
- 97
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 30,519 | 54,533 | 57,283 | 33,387 | 26,821 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17,404 | 17,030 | 14,098 | 15,490 | 16,043 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 58,226 | 80,626 | 83,300 | 60,463 | 55,044 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 84,681 | 81,099 | 93,409 | 79,203 | 75,699 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 193,391 | 209,615 | 229,861 | 224,150 | 215,848 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 80,636 | 77,500 | 80,643 | 109,055 | 108,909 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 127,629 | 129,175 | 146,857 | 178,888 | 171,906 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 65,762 | 80,441 | 83,004 | 45,262 | 43,942 |
Total Liabilities & Shareholders' Equity | 193,391 | 209,615 | 229,861 | 224,150 | 215,848 |
Total Common Shares Outstanding |